BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. It’s a 15-amino-acid sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) that’s been studied primarily in animal models for its potential regenerative and protective effects on tissues. It’s not approved by the FDA for human use and is classified as a research chemical in most places, often sold in lyophilized (freeze-dried) powder form like the 10mg vials you’re referencing.

Common Uses and Research Claims

BPC-157 is popular in biohacking, bodybuilding, and recovery communities for:

• Tissue repair: Accelerating healing of tendons, ligaments, muscles, and bones (e.g., studies in rats show faster Achilles tendon repair).
• Gut health: Protecting and repairing the gastrointestinal tract (e.g., countering NSAID-induced damage in rodent models).
• Anti-inflammatory effects: Reducing inflammation and pain in injury models.
• Neuroprotection: Potential benefits for brain injuries, stroke recovery, and mood disorders in preclinical studies.
• Other: Wound healing, vascular repair, and counteracting alcohol/steroid damage.

Key Evidence:

No large-scale human clinical trials exist due to its unapproved status. It’s banned by WADA for athletes.

10mg Vial: Preparation and Dosing

A 10mg vial is typically reconstituted for injection or oral use. Here’s a standard protocol (for informational purposes only—not medical advice):

1. Reconstitution:

• Use bacteriostatic water (BAC) or sterile saline. Store refrigerated post-reconstitution (stable 4-6 weeks).

2. Dosing Protocols (from research/anecdotal sources):

• Cycle: 4-6 weeks on, 2 weeks off. Total from 10mg vial: ~20-50 doses at 500mcg.

3. Administration Tips:
   • Use insulin syringes (0.3-1ml, 30-31G).
   • Stable orally due to gastric origin.
   • Side effects rare in reports: mild nausea, dizziness, or injection site irritation. No toxicity in animal LD50 tests.

Legality and Risks

• Legal: Research chemical only—not for human consumption in the US/EU. Gray market via peptide vendors (e.g., purity 98-99% via HPLC testing).
• Risks: Unknown long-term human safety. Potential for contamination in unregulated products. Interacts with blood pressure meds or anticoagulants theoretically.
• Sourcing: Test for purity (e.g., Janoshik analytics). Avoid if pregnant, nursing, or with cancer history (angiogenic properties).